Loading...
XLONBMK
Market cap277mUSD
Jan 07, Last price  
30.00GBP
1D
-1.64%
1Q
-25.83%
Jan 2017
-63.79%
IPO
-61.47%
Name

Benchmark Holdings PLC

Chart & Performance

D1W1MN
XLON:BMK chart
P/E
—
P/S
245.78
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
5.77%
Rev. gr., 5y
-6.63%
Revenues
90m
-46.68%
18,546,00027,545,00035,354,00044,199,000109,375,000140,172,000151,467,000127,343,000105,565,000125,062,000158,277,000169,476,00090,365,000
Net income
-39m
L+70.50%
2,782,0004,294,000-1,315,000-11,988,000-18,337,000-7,440,000-5,009,000-73,291,000-22,775,000-11,576,000-30,451,000-23,146,000-39,464,000
CFO
2m
-89.98%
2,362,0005,518,000-537,000-8,959,000-10,532,00013,379,000-3,741,000-9,211,000-4,056,0005,790,00010,810,00020,005,0002,004,000
Earnings
Feb 13, 2025

Profile

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass/bream, salmon, shrimp, and tilapia breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was founded in 2000 and is headquartered in Sheffield, the United Kingdom.
URL
https://www.benchmarkplc.com/
IPO date
Dec 18, 2013
Employees
847
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
90,365
-46.68%
169,476
7.08%
158,277
26.56%
Cost of revenue
48,861
91,232
81,840
Unusual Expense (Income)
NOPBT
41,504
78,244
76,437
NOPBT Margin
45.93%
46.17%
48.29%
Operating Taxes
(1,646)
3,365
7,274
Tax Rate
4.30%
9.52%
NOPAT
43,150
74,879
69,163
Net income
(39,464)
70.50%
(23,146)
-23.99%
(30,451)
163.05%
Dividends
Dividend yield
Proceeds from repurchase of equity
63
13,020
20,737
BB yield
-0.02%
-4.78%
-7.58%
Debt
Debt current
69,233
20,045
17,091
Long-term debt
6,463
101,814
119,332
Deferred revenue
Other long-term liabilities
1,607
31,648
8,996
Net debt
52,608
81,762
96,896
Cash flow
Cash from operating activities
2,004
20,005
10,810
CAPEX
(3,509)
(5,953)
(12,721)
Cash from investing activities
(2,832)
(5,272)
(11,216)
Cash from financing activities
(10,971)
(12,327)
(6,922)
FCF
35,404
119,942
(951)
Balance
Cash
23,088
36,525
36,399
Long term investments
3,572
3,128
Excess cash
18,570
31,623
31,613
Stockholders' equity
152,825
245,189
(97,539)
Invested Capital
279,376
384,641
529,745
ROIC
13.00%
16.38%
13.22%
ROCE
13.48%
18.80%
16.61%
EV
Common stock shares outstanding
739,575
731,935
698,233
Price
0.40
7.53%
0.37
-5.10%
0.39
-35.74%
Market cap
295,830
8.65%
272,280
-0.52%
273,707
-32.98%
EV
354,443
360,254
380,489
EBITDA
90,353
115,452
115,495
EV/EBITDA
3.92
3.12
3.29
Interest
8,045
10,501
11,416
Interest/NOPBT
19.38%
13.42%
14.94%